A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 53
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : CG
Long Form : collagen-glycosaminoglycan
No. Year Title Co-occurring Abbreviation
2019 Neuroprotective Effects of Collagen-Glycosaminoglycan Matrix Implantation following Surgical Brain Injury. GM-CSF, IL-6, MPO, SBI, TNF-alpha
2019 Platelet-derived growth factor stabilises vascularisation in collagen-glycosaminoglycan scaffolds in vitro. hMSCs, PDGF
2019 The influence of cyclic tensile strain on multi-compartment collagen-GAG scaffolds for tendon-bone junction repair. CTS, MSCs, TBJ
2018 Incorporation of the Amniotic Membrane as an Immunomodulatory Design Element in Collagen Scaffolds for Tendon Repair. AM, C/CS, MSCs
2017 The influence of pore size and stiffness on tenocyte bioactivity and transcriptomic stability in collagen-GAG scaffolds. ---
2016 Effect of collagen-glycosaminoglycan scaffold pore size on matrix mineralization and cellular behavior in different cell types. MSCs, OCN, OPN
2015 Bioactive IGF-1 release from collagen-GAG scaffold to enhance cartilage repair in vitro. IGF-1, OA
2015 Controlled-rate freezing to regulate the structure of collagen-glycosaminoglycan scaffolds in engineered skin substitutes. CRF, ESS
2015 The effect of glycosaminoglycan content on polyethylenimine-based gene delivery within three-dimensional collagen-GAG scaffolds. PEI
10  2014 Award Winner in the Young Investigator Category, 2014 Society for Biomaterials Annual Meeting and Exposition, Denver, Colorado, April 16-19, 2014: Periodically perforated core-shell collagen biomaterials balance cell infiltration, bioactivity, and mechanical properties. ECM, SIS
11  2014 Collagen-glycosaminoglycan matrix implantation promotes angiogenesis following surgical brain trauma. SBI
12  2014 Photopatterning of vascular endothelial growth factor within collagen-glycosaminoglycan scaffolds can induce a spatially confined response in human umbilical vein endothelial cells. BP, VEGF
13  2014 Strategies to balance covalent and non-covalent biomolecule attachment within collagen-GAG biomaterials. BP
14  2014 Structural and biochemical modification of a collagen scaffold to selectively enhance MSC tenogenic, chondrogenic, and osteogenic differentiation. MSC, TBJ
15  2012 Addition of hyaluronic acid improves cellular infiltration and promotes early-stage chondrogenesis in a collagen-based scaffold for cartilage tissue engineering. CCS, CHyA, CS, GAGs, HyA, MSCs
16  2012 Mesenchymal stem cell fate is regulated by the composition and mechanical properties of collagen-glycosaminoglycan scaffolds. CS, DHT, ECM, EDAC, GAG, HyA, MSC
17  2012 The application of tissue engineering in reversing mitomycin C-induced ischemic conjunctiva. ---
18  2011 The development of collagen-GAG scaffold-membrane composites for tendon tissue engineering. ---
19  2011 The effect of anisotropic collagen-GAG scaffolds and growth factor supplementation on tendon cell recruitment, alignment, and metabolic activity. ---
20  2011 Three hours of perfusion culture prior to 28 days of static culture, enhances osteogenesis by human cells in a collagen GAG scaffold. ---
21  2010 A novel collagen scaffold supports human osteogenesis--applications for bone tissue engineering. ---
22  2010 A prediction of cell differentiation and proliferation within a collagen-glycosaminoglycan scaffold subjected to mechanical strain and perfusive fluid flow. CT, MSC
23  2010 Novel freeze-drying methods to produce a range of collagen-glycosaminoglycan scaffolds with tailored mean pore sizes. ---
24  2010 Stimulation of osteoblasts using rest periods during bioreactor culture on collagen-glycosaminoglycan scaffolds. ---
25  2010 Substrate stiffness and contractile behaviour modulate the functional maturation of osteoblasts on a collagen-GAG scaffold. DHT, GLUT
26  2010 The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. ---
27  2010 The healing of bony defects by cell-free collagen-based scaffolds compared to stem cell-seeded tissue engineered constructs. CCP
28  2010 Understanding the effect of mean pore size on cell activity in collagen-glycosaminoglycan scaffolds. ---
29  2009 A comparative study of shear stresses in collagen-glycosaminoglycan and calcium phosphate scaffolds in bone tissue-engineering bioreactors. CFD
30  2009 The effect of dehydrothermal treatment on the mechanical and structural properties of collagen-GAG scaffolds. DHT
31  2008 Efficacy and safety of biodegradable collagen-glycosaminoglycan polymer as a material for scleral buckling. ---
32  2008 Gene expression by marrow stromal cells in a porous collagen-glycosaminoglycan scaffold is affected by pore size and mechanical stimulation. MSC
33  2008 [Preliminary study of BMSCs seeded into collagen I-glycosaminoglycan matrices induced toward cartilage]. DHT
34  2007 Collagen scaffolds for nonviral IGF-1 gene delivery in articular cartilage tissue engineering. GSCG, IGF
35  2007 Lithography Technique for Topographical Micropatterning of Collagen-Glycosaminoglycan Membranes for Tissue Engineering Applications. BAEC's, TE
36  2007 Mechanical characterization of collagen-glycosaminoglycan scaffolds. ECM
37  2006 Characterisation of the nanoporous structure of collagen-glycosaminoglycan hydrogels by freezing-out of bulk and bound water. TSD
38  2006 Effect of expansion medium on ex vivo gene transfer and chondrogenesis in type II collagen-glycosaminoglycan scaffolds in vitro. GAG, IGF-1
39  2006 Fabricating tubular scaffolds with a radial pore size gradient by a spinning technique. ---
40  2006 Preliminary study of mesenchymal stem cells-seeded type I collagen-glycosaminoglycan matrices for cartilage repair. DHT, MSCs, SMA
41  2005 The effect of pore size on cell adhesion in collagen-GAG scaffolds. ---
42  2004 Gene delivery to cartilage defects using coagulated bone marrow aspirate. ---
43  2004 Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds. ---
44  2003 The effect of selected growth factors on human anterior cruciate ligament cell interactions with a three-dimensional collagen-GAG scaffold. ACL, SMA
45  2002 Regeneration of neomucosa using cell-seeded collagen-GAG matrices in athymic mice. ---
46  2001 Reduction of abdominal adhesions using composite collagen-GAG implants for ventral hernia repair. PP
47  2001 The effects of cross-linking of collagen-glycosaminoglycan scaffolds on compressive stiffness, chondrocyte-mediated contraction, proliferation and biosynthesis. DHT, EDAC, GTA, UV
48  2001 The migration of cells from the ruptured human anterior cruciate ligament into collagen-glycosaminoglycan regeneration templates in vitro. ACL, SMA
49  2000 Inhibition of conjunctival scarring and contraction by a porous collagen-glycosaminoglycan implant. ---
50  1999 Comparison of cultured and uncultured keratinocytes seeded into a collagen-GAG matrix for skin replacements. ECMA
51  1998 Collagen-GAG substrate enhances the quality of nerve regeneration through collagen tubes up to level of autograft. ---
52  1995 Pore strain behaviour of collagen-glycosaminoglycan analogues of extracellular matrix. SEM
53  1990 Partial dermal regeneration is induced by biodegradable collagen-glycosaminoglycan grafts. ---